Evidence map›Paper›PMID 39806589›Full record

ArticleBMJ open2024

Mailed smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: protocol for a hybrid type 1 effectiveness - implementation trial.

Jamie Bryant, Kayden Roberts-Barker, Zabowie Mills, Kade Booth, Joley Foster, Amanual Getnet Mersha, Raglan Maddox, Catherine Chamberlain, Billie Bonevski, Cathy Segan and 2 more

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. BMJ open · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jamie BryantThe University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia Jamie.Bryant@newcastle.edu.au.ORCID http://orcid.org/0000-0001-9378-5852
Kayden Roberts-BarkerThe University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia.
Zabowie MillsThe University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia.
Kade BoothThe University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia.
Joley FosterThe University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia.
Amanual Getnet MershaThe University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia.
Raglan MaddoxAustralian National University National Centre for Indigenous Studies, Canberra, Australian Capital Territory, Australia.
Catherine ChamberlainThe University of Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-3446-0227
Billie BonevskiFlinders University College of Medicine and Public Health, Bedford Park, South Australia, Australia.
Cathy SeganThe University of Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.
Nathan TaylorAboriginal Health & Medical Research Council, Sydney, New South Wales, Australia.
Michelle KennedyThe University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia.ORCID http://orcid.org/0000-0001-9691-068X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSmoking is the leading preventable cause of death and the single most significant risk behaviour contributing to adverse health conditions among Aboriginal and Torres Strait Islander people. There is an urgent need for innovative approaches to support reductions in smoking prevalence. This study will assess the implementation and effectiveness of a mailed smoking cessation support programme that includes nicotine replacement therapy (NRT) ( METHODS AND ANALYSIS: A hybrid type 1 effectiveness-implementation trial will be conducted in Australia from 2023 to 2025. A sample of 500 Aboriginal and Torres Strait Islander people aged over 16 who smoke will be recruited using social media. All participants will: (a) receive a mailed ETHICS AND DISSEMINATION: Ethics approvals were obtained from Aboriginal Health and Medical Research Council Ethics Committee of NSW (1894/21) and the University of Newcastle (H-2022-0174). Findings will be disseminated through publications, conference presentations and sharing with relevant government bodies. TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry (ACTRN12623001021662).

Indexed as

Australian Aboriginal and Torres Strait Islander PeoplesSmoking CessationAdultAustraliaFemaleHumansMalePostal ServiceTobacco Use Cessation DevicesPREVENTIVE MEDICINEPUBLIC HEALTHSmoking ReductionSubstance misuse

Identifiers

PMID39806589
PMCPMC11667406

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.